Thistle Mary

CIK 00013179178 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001317917

Recent Transactions

47 trades

Award
Q32 Bio Inc.$QTTB
Stock Option (Right to Buy)
2025-10-23+53,521→ 53,521 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Common Stock
2025-08-05−5,000→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−18,068→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−13,928→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−12,155→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2025-08-05−24,309→ 0 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2025-06-11+19,000→ 19,000 total
Award
Vigil Neuroscience, Inc.
Common Stock
2025-05-22+5,000→ 5,000 total
Disposition to Issuer
Q32 Bio Inc.$QTTB
Stock Option (Right to Buy)
2025-02-24−12,767→ 0 total
Award
Q32 Bio Inc.$QTTB
Stock Option (Right to Buy)
2025-02-24+12,767→ 12,767 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-08-08+25,743→ 25,743 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2024-06-13+16,000→ 16,000 total
Award
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-06-05+18,068→ 18,068 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03−24,309→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03−13,928→ 0 total
Disposition to Issuer
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03−12,155→ 0 total
Award
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03+13,928→ 13,928 total
Award
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03+12,155→ 12,155 total
Award
Vigil Neuroscience, Inc.
Stock Option Award (Right to Buy)
2024-05-03+24,309→ 24,309 total
Award
Q32 Bio Inc.$QTTB
Stock Option (Right to Buy)
2024-03-25+12,767→ 12,767 total
Award
Q32 Bio Inc.$QTTB
Option (Right to Buy)
2023-06-14+23,000→ 23,000 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-06-08+16,000→ 16,000 total
Award
Vigil Neuroscience, Inc.
Stock Option Grant (Right to Buy)
2023-06-07+13,928→ 13,928 total
Award
Alaunos Therapeutics, Inc.$TCRT
Employee Stock Option (right to buy)
2023-06-06+100,000→ 100,000 total
Award
Alaunos Therapeutics, Inc.$TCRT
Employee Stock Option (right to buy)
2022-06-22+100,000→ 100,000 total
Award
Alaunos Therapeutics, Inc.$TCRT
Employee Stock Option (right to buy)
2022-06-22+100,000→ 100,000 total
Award
Alaunos Therapeutics, Inc.$TCRT
Common Stock
2022-06-22+40,000→ 45,000 total
Award
Alaunos Therapeutics, Inc.$TCRT
Common Stock
2022-06-22+40,000→ 45,000 total
Award
Q32 Bio Inc.$QTTB
Option (Right to Buy)
2022-06-15+18,000→ 18,000 total
Award
Vigil Neuroscience, Inc.
Stock Option Grant (Right to Buy)
2022-06-09+12,155→ 12,155 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2022-06-02+11,918→ 11,918 total
Award
Vigil Neuroscience, Inc.
Stock Option Grant (Right to Buy)
2022-04-18+24,309→ 24,309 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2021-10-28+11,918→ 11,918 total
Award
Q32 Bio Inc.$QTTB
Option (Right to Buy)
2021-06-17+18,000→ 18,000 total
Award
Alaunos Therapeutics, Inc.$TCRT
Stock Option (right to buy)
2021-03-04+37,500→ 37,500 total
Award
Alaunos Therapeutics, Inc.$TCRT
Stock Option (right to buy)
2021-03-04+150,000→ 150,000 total
Award
Alaunos Therapeutics, Inc.$TCRT
Common Stock
2021-03-04+5,000→ 5,000 total
Award
Q32 Bio Inc.$QTTB
Option (Right to Buy)
2020-06-10+18,000→ 18,000 total
Award
Q32 Bio Inc.$QTTB
Option (Right to Buy)
2019-06-06+15,580→ 15,580 total
Award
Q32 Bio Inc.$QTTB
Employee stock option
2018-03-27+31,160→ 31,160 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−27,711→ 0 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−60,000→ 0 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−65,000→ 0 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−17,104→ 0 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−180,815→ 0 total
Award
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-02-01+60,000→ 60,000 total
Award
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2016-02-01+65,000→ 65,000 total

Companies

Recent Filings

Address

C/O AKTIS ONCOLOGY, INC. 17 DRYDOCK AVENUE, SUITE 17-401

BOSTON, MA, 02210

View on SEC.gov